News

Filter

Current filters:

GlaxoSmithKlineCervarix

1 to 9 of 105 results

FDA “Breakthrough Therapy” designation for GSK’s malaria drug tafenoquine; EU Cervarix news

FDA “Breakthrough Therapy” designation for GSK’s malaria drug tafenoquine; EU Cervarix news

22-12-2013

The US Food and Drug Administration has granted “Breakthrough Therapy” designation for tafenoquine,…

CervarixEuropeGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationtafenoquineTropical diseases

CHMP positive opinion for GSK’s Cervarix two-dose schedule

CHMP positive opinion for GSK’s Cervarix two-dose schedule

28-11-2013

UK pharma giant GlaxoSmithKline says that the European Medicines Agency's Committee for Medicinal Products…

CervarixEuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVaccines

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

18-11-2013

Despite being hampered both by apathy and resistance in recent years, the human papillomavirus (HPV)…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalV503VaccinesWomen's Health

Uptake of HPV vaccines must increase to reap rewards

Uptake of HPV vaccines must increase to reap rewards

08-11-2013

Here's our take on the week's top stories.

CervarixGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalVaccines

New data support GSK’s Cervarix two-dose schedule

New data support GSK’s Cervarix two-dose schedule

04-11-2013

UK pharma giant GlaxoSmithKline has revealed the results of a Phase III study of its HPV vaccine, Cervarix,…

CervarixGlaxoSmithKlineOncologyPharmaceuticalResearchVaccines

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA

21-06-2013

The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

Merck & Co's Gardasil and GSK's Cervarix to be available to developing countries via UNICEF tender

09-05-2013

A new record low price for human papillomavirus (HPV) vaccines will help ensure millions of girls in…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingRest of the World

1 to 9 of 105 results

COMPANY SPOTLIGHT

Menarini

Back to top